Crossmark Global Holdings Inc. raised its stake in shares of Cigna Corp (NYSE:CI) by 13.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 29,869 shares of the health services provider’s stock after purchasing an additional 3,572 shares during the period. Crossmark Global Holdings Inc.’s holdings in Cigna were worth $6,108,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently modified their holdings of the company. Braun Bostich & Associates Inc. purchased a new position in Cigna during the 4th quarter valued at approximately $26,000. Garrett Wealth Advisory Group LLC purchased a new position in Cigna during the 3rd quarter valued at approximately $30,000. Knuff & Co LLC purchased a new position in Cigna during the 3rd quarter valued at approximately $30,000. Optimum Investment Advisors grew its holdings in Cigna by 258.6% during the 3rd quarter. Optimum Investment Advisors now owns 208 shares of the health services provider’s stock valued at $32,000 after buying an additional 150 shares in the last quarter. Finally, Massey Quick Simon & CO. LLC purchased a new position in Cigna during the 3rd quarter valued at approximately $43,000. Hedge funds and other institutional investors own 87.48% of the company’s stock.

A number of equities analysts have recently commented on the company. SunTrust Banks reiterated a “buy” rating and issued a $280.00 target price on shares of Cigna in a report on Friday, February 7th. UBS Group lifted their target price on Cigna from $222.00 to $244.00 and gave the stock a “buy” rating in a report on Tuesday, January 28th. Morgan Stanley lifted their target price on Cigna from $247.00 to $248.00 and gave the stock an “overweight” rating in a report on Friday, February 7th. Wells Fargo & Co lowered shares of Cigna from a “market perform” rating to an “underperform” rating and set a $181.00 price objective for the company. in a research note on Wednesday, December 11th. Finally, Citigroup lifted their price objective on shares of Cigna from $221.00 to $263.00 and gave the stock a “buy” rating in a research note on Thursday, January 23rd. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and sixteen have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $237.05.

In related news, insider Timothy C. Wentworth sold 21,708 shares of the business’s stock in a transaction that occurred on Friday, February 7th. The stock was sold at an average price of $209.73, for a total value of $4,552,818.84. Following the completion of the sale, the insider now owns 70,374 shares in the company, valued at $14,759,539.02. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Steven B. Miller sold 7,145 shares of the business’s stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $212.15, for a total value of $1,515,811.75. Following the completion of the sale, the executive vice president now owns 32,071 shares of the company’s stock, valued at approximately $6,803,862.65. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 51,545 shares of company stock worth $10,612,704. Company insiders own 0.80% of the company’s stock.

CI opened at $221.89 on Friday. The business has a fifty day moving average of $206.20 and a 200 day moving average of $181.01. The stock has a market cap of $78.54 billion, a P/E ratio of 16.52, a PEG ratio of 1.00 and a beta of 0.79. The company has a quick ratio of 0.63, a current ratio of 0.43 and a debt-to-equity ratio of 0.70. Cigna Corp has a 52-week low of $141.95 and a 52-week high of $224.64.

Cigna (NYSE:CI) last released its earnings results on Thursday, February 6th. The health services provider reported $4.31 earnings per share for the quarter, topping analysts’ consensus estimates of $4.20 by $0.11. Cigna had a return on equity of 14.69% and a net margin of 3.32%. The business had revenue of $36.54 billion for the quarter, compared to analyst estimates of $35.20 billion. During the same quarter last year, the firm posted $2.46 earnings per share. The business’s revenue was up 165.7% compared to the same quarter last year. Equities analysts anticipate that Cigna Corp will post 18.51 EPS for the current fiscal year.

Cigna Profile

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

See Also: What causes a stock to be most active?

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.